Teleflex Incorporated Stock News

Related Stocks: SBNY , UTHR , PANW , MRVI , ALB , CONE , TTD , BLMN , TFX , TWLO , FIVN , FL , OC , VFC ,

Related Stocks: MSI , DXCM , BRKR , A , BURL , WEN , JCI , HUBS , LYV , PLTR , ALK , MCB , MU , MRNA , NXST , FCX , RNG , VMEO , TFX , AKAM , CCK , BAH , ALGN , HEI ,

The Heart Pump Device Market research report provides broad, subjective bits of knowledge on the potential and specialty portions or regions displaying good growth. The Heart Pump Device Market research report comprehensively investigates the current and developing business sector patterns

Teleflex (NYSE:TFX) had its price target reduced by Wells Fargo & Company from $450.00 to $355.00 in a research report released on Monday, The Fly reports. Wells Fargo & Company currently has an overweight rating on the medical technology companys stock. A number of other equities analysts also recently weighed in on the stock. Royal []

The Global Medical Bronchoscopy Market 2021-2028 study provides critical information related to the global, regional and top players including Medical Bronchoscopy market share analysis, winning strategies, recent developments, and financial planning. The report provides key statistics on the market status

Telemus Capital LLC increased its holdings in Teleflex Incorporated (NYSE:TFX) by 5.1% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 3,024 shares of the medical technology company’s stock after buying an additional 148 shares during the period. Telemus Capital LLC’s holdings in Teleflex were worth $1,139,000 […]

Despite reporting softer-than-expected revenues for the third quarter, Teleflex (TFX) notes that customer preference for UroLift continues to be driven by strong clinical results.

DekaBank Deutsche Girozentrale grew its position in shares of Teleflex Incorporated (NYSE:TFX) by 0.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,996 shares of the medical technology company’s stock after purchasing an additional 61 shares during the quarter. […]

This Ligation Clips market report gives exhaustive bits of knowledge into the different industry characteristics like approaches, patterns and key players working in various districts. In arrange to supply exact and critical information related to showcase situation and development,

Teleflex (NYSE:TFX) had its target price reduced by Wells Fargo & Company from $450.00 to $355.00 in a research note issued to investors on Monday morning, The Fly reports. They currently have an overweight rating on the medical technology company’s stock. Several other equities research analysts have also recently weighed in on the company. Royal […]

Royal Bank of Canada started coverage on shares of Teleflex (NYSE:TFX) in a research report report published on Thursday morning, The Fly reports. The firm issued an outperform rating and a $415.00 price objective on the medical technology company’s stock. A number of other research firms have also issued reports on TFX. Raymond James cut […] The post Teleflex (NYSE:TFX) Earns Outperform Rating from Analysts at Royal Bank of Canada appeared first on ETF Daily News .

Crossmark Global Holdings Inc. cut its position in shares of Teleflex Incorporated (NYSE:TFX) by 2.8% in the third quarter, Holdings Channel reports. The institutional investor owned 3,128 shares of the medical technology companys stock after selling 90 shares during the period. Crossmark Global Holdings Inc.s holdings in Teleflex were worth $1,178,000 as of its most []

Related Stocks: TNDM , NCNO , SHLS , MKSI , SF , TFX , MTN , WK , CNM , AXNX , AMRC , STVN , ZEN , TXG , HUBS , HEI.A , KTOS , NVRO ,

Merit Medical Systems (NASDAQ:MMSI) and Teleflex (NYSE:TFX) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, analyst recommendations and earnings. Risk and Volatility Merit Medical Systems has a beta of 1.13, suggesting that its share price []